Related Experiment Video
Updated: Mar 9, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Hereditary Hemorrhagic Telangiectasia and Myocardial Infarction
Efrén Martínez-Quintana1, Fayna Rodríguez-González1, Silvia Gopar-Gopar2
1Ophthalmology Service, Dr Negrín University Hospital of Gran Canaria, Las Palmas de Gran Canaria, Spain.
Abstract:
Hereditary hemorrhagic telangiectasia, also known as Osler-Weber-Rendu syndrome, is an autosomal dominant genetic disorder that leads to epistaxis, gastrointestinal bleeding, iron deficiency anemia, and arteriovenous malformations at the lungs, the liver, and the brain. However, due to its rarity and its unspecific findings on routine examinations, diagnosis is not easy unless suspected due to hypoxemia or paradoxical embolism. We present a case of a 46-year-old-woman with hereditary hemorrhagic telangiectasia and hypoxemia who presented a myocardial infarction secondary to paradoxical embolism through pulmonary arteriovenous malformations.
More Related Videos
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Myocarditis I: Introduction
Esophageal Varices-I: Introduction
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Cardiomyopathy I: Introduction and Classification
Anticoagulant Drugs: Low-Molecular-Weight Heparins

